Zevra Therapeutics, Inc. ( NASDAQ: ZVRA) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Nichol Ochsner - VP, IR and Corporate Communications Neil McFarlane - President and CEO LaDuane ...

Zevra Therapeutics Inc. (ZVRA) reported a net loss of $35.7 million for Q4 2024, equating to a loss of $0.67 per share, which was below analyst expectations of a $0.40 loss per share. The company ...

Zevra Therapeutics Inc. (ZVRA) reported a net loss of $35.7 million for Q4 2024, equating to a loss of $0.67 per share, which was below analyst expectations of a $0.40 loss per share. The company ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.